ORYZON Announces First Patient In in FRIDA, a Phase Ib Trial With Iadademstat in Relapsed/Refractory FLT3-mutant Acute Myeloid Leukemia Patients
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D Secondary objectives: to…
Should the Front Office-Back Office Divide End?
Durabook Introduces the R12 Rugged Tablet Active Edge AI Platform
IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers